IGC Pharma, Inc. fell 10.0% on Thursday, November 12, 2026, on 363,700 shares. No headline about IGC came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
IGC Pharma, Inc. (IGC:NYSEMKT) closed at $0.176 on November 13, 2026, down 4.61% on the day. The stock trades 52.4% below its 52-week high of $0.370 and 120.0% above its 52-week low of $0.080. Over the past year, it lost 51.1%. IGC Pharma, Inc. is part of the Technology sector (Electronic Components).
In 252 trading sessions since November 13, 2025, IGC closed higher on 56 days (22%). Its best day was December 10, 2025 (+13.33%) and its worst was October 29, 2026 (-16.67%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 2 times.
India Globalization Capital, Inc. engages in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. The company was founded in 2005 and is based in Bethesda, Maryland.
Find more stocks like IGC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.